FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021777493> ?p ?o ?g. }

• W3021777493 abstract "Abstract Background Candida is the leading cause of vaginitis, and 75% of women have at least one episode of infection in their lives, with pregnancy being a predisposing factor. If left untreated, vulvovaginal candidiasis (VVC) can lead to chorioamnionitis with subsequent abortion, prematurity and congenital infection of the neonate. We aimed to determine the prevalence of VVC, identify the recent and most frequently occurring species of Candida in pregnant women, and determine the most effective antifungal drug of choice for treatment. Method A prospective cross-sectional study in which 176 high vaginal swab samples of consented pregnant women visiting the antenatal clinic from February 2018 to April 2018 were subjected to direct gram smear and culture for Candida isolation. Candida isolates were identified using a germ tube test and HiCrome Candida differential agar. Candida isolates were then subjected to a disk diffusion method using fluconazole (25 μg), nystatin (100 units), and voriconazole (1 μg) on Mueller-Hinton agar supplemented with 2% (w/v) glucose and 0.5 μg/ml methylene blue dye to determine the susceptibility pattern as per the guidelines of the Clinical Laboratory Standard Institute (CLSI). Chi-square analysis was used to ascertain the significant association of participants’ sociodemographics and clinical presentations to VVC. A univariate logistic regression model was used to identify potential risk factors of VVC. Results The prevalence of VVC among our study participants was 30.7%. Non- albicans Candida (NAC) and Candida albicans had a prevalence of 74.1 and 25.9%, respectively. Candida glabrata was the most common species, followed by Candida albicans , Candida krusei , and Candida parapsilosis . 50.0, 18.5 and 3.7% of Candida species were susceptible to voriconazole, fluconazole and nystatin, respectively, whereas 37.0, 48.1 and 9.3% of Candida species were resistant to voriconazole, fluconazole and nystatin, respectively. The majority of isolates were susceptible dose dependent to all three antifungal agents, with voriconazole being the most efficacious antifungal agent. There was no significant association between participants’ socio-demographic information and clinical presentations to VVC. Conclusion The prevalence of VVC was high in the study area. C. glabrata was found to be the most common cause of VVC among the pregnant women attending antenatal clinics, in the Ho Municipality region of Ghana. The majority of the Candida isolates were susceptible and resistant to voriconazole and fluconazole, respectively." @default.
• W3021777493 created "2020-05-13" @default.
• W3021777493 creator A5004735867 @default.
• W3021777493 creator A5005178272 @default.
• W3021777493 creator A5005414884 @default.
• W3021777493 creator A5014033638 @default.
• W3021777493 creator A5028690269 @default.
• W3021777493 creator A5034601282 @default.
• W3021777493 creator A5035055418 @default.
• W3021777493 creator A5044406905 @default.
• W3021777493 creator A5048272787 @default.
• W3021777493 creator A5055333424 @default.
• W3021777493 creator A5066103499 @default.
• W3021777493 creator A5067687478 @default.
• W3021777493 creator A5072363062 @default.
• W3021777493 creator A5079220651 @default.
• W3021777493 creator A5080162340 @default.
• W3021777493 date "2020-05-06" @default.
• W3021777493 modified "2023-10-16" @default.
• W3021777493 title "Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates" @default.
• W3021777493 cites W1593596797 @default.
• W3021777493 cites W1984334021 @default.
• W3021777493 cites W1995081245 @default.
• W3021777493 cites W2007388866 @default.
• W3021777493 cites W2014274859 @default.
• W3021777493 cites W2026041359 @default.
• W3021777493 cites W2030501428 @default.
• W3021777493 cites W2033628934 @default.
• W3021777493 cites W2034089384 @default.
• W3021777493 cites W2041867807 @default.
• W3021777493 cites W2062165991 @default.
• W3021777493 cites W2063047956 @default.
• W3021777493 cites W2071912405 @default.
• W3021777493 cites W2078647560 @default.
• W3021777493 cites W2082534857 @default.
• W3021777493 cites W2086319394 @default.
• W3021777493 cites W2092491117 @default.
• W3021777493 cites W2113916306 @default.
• W3021777493 cites W2117201278 @default.
• W3021777493 cites W2120407264 @default.
• W3021777493 cites W2122090901 @default.
• W3021777493 cites W2143266176 @default.
• W3021777493 cites W2152046772 @default.
• W3021777493 cites W2161710216 @default.
• W3021777493 cites W2161750300 @default.
• W3021777493 cites W2312506942 @default.
• W3021777493 cites W241262881 @default.
• W3021777493 cites W2591595861 @default.
• W3021777493 cites W2596365274 @default.
• W3021777493 cites W2614676839 @default.
• W3021777493 cites W2755441990 @default.
• W3021777493 cites W2771675060 @default.
• W3021777493 cites W2773056368 @default.
• W3021777493 cites W2807934072 @default.
• W3021777493 cites W2975611946 @default.
• W3021777493 cites W4211042503 @default.
• W3021777493 cites W4249599166 @default.
• W3021777493 cites W95502085 @default.
• W3021777493 doi "https://doi.org/10.1186/s12884-020-02963-3" @default.
• W3021777493 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7201979" @default.
• W3021777493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32375724" @default.
• W3021777493 hasPublicationYear "2020" @default.
• W3021777493 type Work @default.
• W3021777493 sameAs 3021777493 @default.
• W3021777493 citedByCount "31" @default.
• W3021777493 countsByYear W30217774932020 @default.
• W3021777493 countsByYear W30217774932021 @default.
• W3021777493 countsByYear W30217774932022 @default.
• W3021777493 countsByYear W30217774932023 @default.
• W3021777493 crossrefType "journal-article" @default.
• W3021777493 hasAuthorship W3021777493A5004735867 @default.
• W3021777493 hasAuthorship W3021777493A5005178272 @default.
• W3021777493 hasAuthorship W3021777493A5005414884 @default.
• W3021777493 hasAuthorship W3021777493A5014033638 @default.
• W3021777493 hasAuthorship W3021777493A5028690269 @default.
• W3021777493 hasAuthorship W3021777493A5034601282 @default.
• W3021777493 hasAuthorship W3021777493A5035055418 @default.
• W3021777493 hasAuthorship W3021777493A5044406905 @default.
• W3021777493 hasAuthorship W3021777493A5048272787 @default.
• W3021777493 hasAuthorship W3021777493A5055333424 @default.
• W3021777493 hasAuthorship W3021777493A5066103499 @default.
• W3021777493 hasAuthorship W3021777493A5067687478 @default.
• W3021777493 hasAuthorship W3021777493A5072363062 @default.
• W3021777493 hasAuthorship W3021777493A5079220651 @default.
• W3021777493 hasAuthorship W3021777493A5080162340 @default.
• W3021777493 hasBestOaLocation W30217774931 @default.
• W3021777493 hasConcept C126322002 @default.
• W3021777493 hasConcept C131872663 @default.
• W3021777493 hasConcept C145081991 @default.
• W3021777493 hasConcept C16005928 @default.
• W3021777493 hasConcept C2776445003 @default.
• W3021777493 hasConcept C2777617518 @default.
• W3021777493 hasConcept C2779234561 @default.
• W3021777493 hasConcept C2779548794 @default.
• W3021777493 hasConcept C2780651595 @default.
• W3021777493 hasConcept C2780670043 @default.
• W3021777493 hasConcept C2780917455 @default.
• W3021777493 hasConcept C29456083 @default.
• W3021777493 hasConcept C36755584 @default.
• W3021777493 hasConcept C54355233 @default.

• next